40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
68.97%
Cash & equivalents growing 68.97% while CRK's declined -53.90%. Peter Lynch would see this as a sign of superior liquidity management.
No Data
No Data available this quarter, please select a different quarter.
68.97%
Below half of CRK's -53.90%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
26.01%
Higher Net Receivables Growth compared to CRK's zero value, indicating worse performance.
-52.34%
Higher Inventory Growth compared to CRK's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
9.42%
Below half of CRK's -22.97%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
2.32%
0.75-0.9x CRK's 2.88%. Bill Ackman questions if competitor invests more heavily in future capacity.
No Data
No Data available this quarter, please select a different quarter.
-1.38%
Higher Intangible Assets Growth compared to CRK's zero value, indicating worse performance.
-1.38%
Higher Goodwill + Intangibles Growth compared to CRK's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.70%
Less than half of CRK's 30.62%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
2.31%
0.5-0.75x CRK's 3.12%. Martin Whitman wonders if there's insufficient reinvestment vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
2.93%
≥ 1.5x CRK's 1.19%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
19.48%
Less than half of CRK's -1.76%. David Dodd sees a more disciplined AP approach or lower volume.
-34.12%
50-75% of CRK's -62.60%. Bruce Berkowitz notes the firm is less reliant on near-term borrowing than competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1095.77%
Higher Other Current Liabilities Growth compared to CRK's zero value, indicating worse performance.
47.74%
Less than half of CRK's -40.67%. David Dodd sees a more disciplined short-term liability approach.
-0.90%
Less than half of CRK's 10.88%. David Dodd sees more deleveraging vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-8.80%
Above 1.5x CRK's -3.44%. Michael Burry sees a much bigger deferred tax load building up.
27.76%
Above 1.5x CRK's 2.50%. Michael Burry suspects a looming risk from large additions to LT liabilities.
-2.88%
Less than half of CRK's 7.61%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
4.74%
Above 1.5x CRK's 1.01%. Michael Burry sees a potential leverage warning sign.
0.75%
50-75% of CRK's 1.08%. Bruce Berkowitz notes minimal new equity relative to competitor.
2.38%
≥ 1.5x CRK's 0.02%. David Dodd sees higher yoy retained profits than competitor.
-11.16%
Less than half of CRK's -4363.65%. David Dodd sees fewer intangible or market-driven swings than competitor.
No Data
No Data available this quarter, please select a different quarter.
0.87%
0.5-0.75x CRK's 1.50%. Martin Whitman is wary of lagging equity growth vs. competitor.
2.93%
≥ 1.5x CRK's 1.19%. David Dodd sees faster overall balance sheet growth than competitor.
No Data
No Data available this quarter, please select a different quarter.
-2.40%
Less than half of CRK's 10.73%. David Dodd sees less overall debt expansion vs. competitor.
-4.10%
Less than half of CRK's 11.88%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
